SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
LATE-BREAKING NEWS: UPDATE FROM THE HVTN 702 VACCINE (UHAMBO) TRIAL
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
2 of
2
|
INTRODUCTION OF HVTN 702 STUDY
Lawrence Corey
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
PRESENTATION OF HVTN 702 STUDY DATA
Glenda Elisabeth Gray
University of the Witwatersrand, Soweto, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
2 of
2
|
